Product Information

CEFPROZIL 250 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2287 per ML under NDC 68180040201. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Dec 19, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CEFPROZIL 250 MG/5 ML SUSP

CEFPROZIL
$0.2287per ML

Strength

250 mg/5mL

NDC

68180040201

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CEFPROZIL

Approval Type

Generic (ANDA)

FDA Application

ANDA065261

FDA Approved

12/19/2005

TE Code

AB

On Market Since

12/1/2005

Price Statistics

The NADAC for CEFPROZIL 250 MG/5 ML SUSP has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2287 per ML
All-time high$0.5948 (Sep 10, 2014)
All-time low$0.1534 (Aug 17, 2022)
52-week high$0.2680
52-week low$0.2148
Median price$0.3488
Average price$0.3980
Largest weekly change+75.2% (Oct 19, 2022)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.4%

3M

+3.9%

6M

+5.1%

1Y

-10.7%

3Y

+7.3%

5Y

-34.4%

All

-57.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 29%

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CEFPROZIL 250 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 250 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $0.2287 per ML (NDC 68180040201), effective Nov 11, 2026.

How has the price of CEFPROZIL 250 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has declined 57.4%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CEFPROZIL 250 MG/5 ML SUSP?

Since Nov 28, 2013, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has ranged from a low of $0.1534 (Aug 17, 2022) to a high of $0.5948 (Sep 10, 2014), with a median of $0.3488 per ML.

Are there cheaper alternatives to CEFPROZIL 250 MG/5 ML SUSP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFPROZIL 250 MG/5 ML SUSP, is $0.1622 per ML — about 29% below CEFPROZIL 250 MG/5 ML SUSP.

Who manufactures CEFPROZIL 250 MG/5 ML SUSP?

CEFPROZIL 250 MG/5 ML SUSP (NDC 68180040201) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.